Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Eli lilly and company crawled time : 20:00 save search
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published: 2024-04-15 (Crawled : 20:00) - globenewswire.com
BDTX A | $5.22 -0.38% -0.38% 370K
|
Health Technology
| Email alert
Add to watchlist
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
| Email alert
Add to watchlist
CRGX | $19.89 -4.56% -4.38% 140K
|
| Email alert
Add to watchlist
AUTL | $4.9 -2.39% -2.45% 790K
|
Health Technology
| Email alert
Add to watchlist
therapeutics
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
ORIC | $9.54 -2.65% -2.83% 330K
|
Health Technology
|
| O: -2.81%
H: 1.54%
C: -3.57%
NRIX 2 d | $15.46 -7.65% -8.28% 2M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
therapeutics
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 -0.49% 6.88% 130
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $2.0 -5.21% -5.5% 16
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | $94.41 0.95% -1.42% 1.4M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
MURA | $4.09 -3.08% -3.18% 350K
|
|
| O: 3.7%
H: 2.57%
C: 0.22%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
medical therapeutics
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | $92.966 0.07% -2.18% 630
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
NVS | $94.41 0.95% -1.42% 1.4M
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: 0.07%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
ABBV | $161.67 -0.38% -0.19% 3.4M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
investments report antibody reach research global growth market
Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 1.22%
H: 1.78%
C: -1.72%
merck cancer agreement
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
LGND | $79.77 -1.95% -1.85% 55
|
Health Technology
|
| O: 0.29%
H: 1.26%
C: 0.87%
publication pharmaceuticals trial results
Global Premature Ejaculation Therapeutics Market Report 2024-2029: North America and Europe Dominate the Market in 2023, APAC Emerges as the Fastest-Growing Market
Published: 2023-12-08 (Crawled : 20:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
| Email alert
Add to watchlist
JNJ | $147.59 0.05% -0.56% 72K
|
Health Technology
| Email alert
Add to watchlist
america europe report global therapeutics market
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Published: 2023-11-28 (Crawled : 20:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
drug prism collaboration
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
MRUS | $41.27 -1.39% -1.33% 270K
|
Health Technology
|
| O: 3.51%
H: 9.56%
C: 9.56%
INCY | $53.43 -0.78% -0.8% 0
|
Health Technology
|
| O: 0.52%
H: 1.38%
C: 1.11%
business update financial results
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
Published: 2023-09-13 (Crawled : 20:00) - globenewswire.com
NVS | $94.41 0.95% -1.42% 1.4M
|
Health Technology
|
| O: 0.28%
H: 1.0%
C: 0.76%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.77%
H: 0.43%
C: -1.27%
psoriasis treatment preclinical results
Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights
Published: 2023-08-08 (Crawled : 20:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
RNA | $23.91 -0.75% -0.75% 870K
|
Health Technology
|
| O: 6.27%
H: 3.66%
C: -1.48%
financial results
Zymeworks Appoints New Director
Published: 2023-06-29 (Crawled : 20:00) - globenewswire.com
ZYME | $9.09 -1.73% -1.76% 780K
|
Health Technology
|
| O: 0.23%
H: 3.62%
C: 0.93%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.03%
H: 1.12%
C: 0.93%
BGNE S | $138.4 -2.05% -2.1% 10
|
Health Technology
|
| O: -1.08%
H: 1.46%
C: 0.93%
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
Published: 2023-06-27 (Crawled : 20:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -2.09%
CMRX | $0.9146 -4.8% -5.24% 510K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -2.36%
Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period (2019-2032), Estimates DelveInsight
Published: 2023-06-19 (Crawled : 20:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.41%
H: 2.02%
C: 1.37%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: 0.0%
INCY | $53.43 -0.78% -0.8% 0
|
Health Technology
|
| O: 0.3%
H: 0.17%
C: -2.63%
positive show growth study market
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.08%
H: 0.74%
C: -0.07%
MRUS | $41.27 -1.39% -1.33% 270K
|
Health Technology
|
| O: 4.36%
H: 8.41%
C: 5.96%
INCY | $53.43 -0.78% -0.8% 0
|
Health Technology
|
| O: 0.85%
H: 1.46%
C: -0.28%
business update financial results
Global Acute Migraine Drugs Market Report 2023: Markey Insights and Forecasts 2018-2022 & 2023-2028 - Competitive Developments, Strategies, Mergers and Acquisitions and New Product Developments
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $161.67 -0.38% -0.19% 3.4M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
JNJ | $147.59 0.05% -0.56% 72K
|
Health Technology
| Email alert
Add to watchlist
global report acquisitions migraine market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $180.75 -3.98% -19.21% 0
|
n/a
|
| O: -0.86%
H: 0.33%
C: 0.33%
CSLLY | $89.5 -2.2% 3.3% 0
|
n/a
|
| O: -0.02%
H: 0.54%
C: -1.7%
AZNCF | $135.94 -2.12% -4.19% 770
|
Health Technology
|
| O: -2.57%
H: 1.62%
C: 1.62%
TMO | $557.87 -1.3% -0.24% 860K
|
Health Technology
|
| O: 0.41%
H: 0.39%
C: -2.14%
TEVA | $13.23 -0.53% -0.76% 12M
|
Health Technology
|
| O: -1.21%
H: 0.43%
C: -3.58%
TAK | $13.18 -1.42% -0.3% 1.8M
|
Health Technology
|
| O: 0.83%
H: 0.06%
C: -1.2%
PRGO A | $30.13 -0.63% 0.03% 1.7M
|
Health Technology
|
| O: 0.76%
H: 1.91%
C: 1.26%
GSK | $40.5 -0.39% -0.86% 4.9K
|
Health Technology
|
| O: 0.32%
H: 0.17%
C: -1.53%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: 0.01%
H: 0.42%
C: -2.62%
CTLT | $56.08 -0.39% 0.0% 920K
|
Health Technology
|
| O: 0.11%
H: 0.53%
C: -5.05%
BMY | $48.51 0.48% 0.19% 9.8M
|
Health Technology
|
| O: 0.41%
H: 0.04%
C: -1.71%
ALB | $120.5 -1.7% -3.01% 1.5M
|
Process Industries
|
| O: -0.95%
H: 1.02%
C: -2.19%
ABBV | $161.67 -0.38% -0.19% 3.4M
|
Health Technology
|
| O: 0.19%
H: 0.06%
C: -1.7%
SNY | $46.24 0.68% 0.63% 1.6M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
GILD | $67.75 -0.47% -0.46% 2.3K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: -1.25%
BIIB | $196.8 -0.7% -0.72% 86
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -2.26%
AZN | $68.73 -0.29% -0.26% 14K
|
Health Technology
|
| O: 0.9%
H: 0.28%
C: -1.3%
global report market
Lilly to Participate in SVB Securities Global Biopharma Conference
Published: 2023-02-07 (Crawled : 20:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.48%
H: 1.46%
C: 1.08%
biopharma global conference
U.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and Only Non-Covalent (Reversible) BTK Inhibitor, for Adult Patients with Relapsed or Refractory Mantle Cell Lymphoma After at Least Two Lines of Systemic Therapy, Including a BTK Inhibitor
Published: 2023-01-27 (Crawled : 20:00) - biospace.com/
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.55%
H: 0.57%
C: -1.16%
fda
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 51.63% 190K
|
Wholesale Trade
JAGX | $0.1188 31.56% 35.59% 12M
|
Health Technology
HUBC | $1.95 50.0% 33.67% 4.7M
|
n/a
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
ITCI | $64.76 -1.7% 15.38% 690K
|
Health Technology
PTN | $1.82 -5.21% 15.38% 290K
|
Health Technology
VIAO | $0.308 -26.67% 12.01% 390K
|
Electronic Technology
HNRA | $2.36 -9.58% 11.86% 220K
|
n/a
UMAC | $1.85 -2.12% 8.11% 6.1K
|
HLX | $11.11 -4.22% 7.74% 87
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.